RecruitingNCT05044273
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
Evaluation of Effectiveness and Safety of Synergy™ XD Stent and Synergy Megatron™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Sponsor
Jung-min Ahn
Enrollment
2,000 participants
Start Date
Sep 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The objective of this study is to evaluate the effectiveness and safety of Synergy XD stent and Synergy Megatron™ Stent in the "real world" daily practice as compared with the other drug-eluting stents.
Eligibility
Min Age: 19 Years
Inclusion Criteria3
- Patients ≥ 19 years old
- Patients receiving Synergy XD stent(s) or Synergy Megatron™ stent(s).
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria3
- Patients with a mixture of other drug-eluting stents (DESs)
- Terminal illness with life-expectancy ≤1 year.
- Patients with cardiogenic shock
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICESynergy XD stent or Synergy Megatron™ Stent
Percutaneous coronary intervention with Synergy XD stent or Synergy Megatron™ Stent
Locations(23)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05044273
Related Trials
Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry
NCT032096741 location
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731151 locations
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120146 locations
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
NCT0719069012 locations
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
NCT062590194 locations